Importantly, cross reactivity with recombinant mouse EphA2 protein was also demonstrated (KD 3.82 ± 0.56 nM), allowing for the detection of any EphA2 mediated uptake in non-tumor tissue (Table 1, Supplementary Figure 8 and Supplementary Table 1). This evidence concerns the gene EPHA2 and neoplasm.